Cargando…
Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma
Drug resistance mechanisms in renal cell carcinoma (RCC) still remain elusive. Although most patients initially respond to targeted therapy, acquired resistance can still develop eventually. Most of the patients suffer from intrinsic (genetic) resistance as well, suggesting that there is substantial...
Autores principales: | Bielecka, Zofia Felicja, Czarnecka, Anna Małgorzata, Szczylik, Cezary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110478/ https://www.ncbi.nlm.nih.gov/pubmed/25120953 http://dx.doi.org/10.3389/fonc.2014.00194 |
Ejemplares similares
-
Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in
Clear - Cell Renal Cell Carcinoma (ccRCC)
por: Bielecka, Zofia F., et al.
Publicado: (2013) -
Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma
por: Kornakiewicz, Anna, et al.
Publicado: (2013) -
Metastatic renal cell carcinoma cells growing in 3D on poly-D-lysine or laminin present a stem-like phenotype and drug resistance
por: Brodaczewska, Klaudia K., et al.
Publicado: (2019) -
Development of extracellular matrix supported 3D culture of renal cancer cells and renal cancer stem cells
por: Maliszewska-Olejniczak, Kamila, et al.
Publicado: (2018) -
Vitamin D receptor gene polymorphisms in breast and renal cancer: Current state and future approaches
por: KHAN, MOHAMMED I., et al.
Publicado: (2013)